Form 8-K SALIX PHARMACEUTICALS For: Aug 07
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Comscore plans restructuring with $20M-$25M in cost cuts
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Salix Pharma (SLXP), Progenics (PGNX) Receive User Fee Goal Date for Relistor sNDA
August 11, 2014 7:01 AM EDTSalix Pharma (Nasdaq: SLXP) and Progenics Pharmaceuticals (Nasdaq: PGNX) announced that the Food and Drug Administration (FDA or Agency) has informed Salix that the supplemental New Drug Application (sNDA) for RELISTOR (methylnaltrexone bromide) Subcutaneous Injection, 20 mg/ml, for the treatment of opioid-induced constipation (OIC) in patients taking opioids for chronic non-cancer pain has been assigned a user fee goal date of September 29, 2014.
On... More
Salix Pharmaceuticals Ltd (SLXP) Misses Q2 EPS by 10c
August 7, 2014 4:45 PM EDTSalix Pharmaceuticals Ltd (NASDAQ: SLXP) reported Q2 EPS of $1.59, $0.10 worse than the analyst estimate of $1.69. Revenue for the quarter came in at $382 million versus the consensus estimate of $397.06 million.
For earnings history and earnings-related data on Salix Pharmaceuticals Ltd (SLXP) click here.
... More